Metraipolis › archive › dc_735c5d33cd02

Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening — Europe PMC PMID:41923265

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41923265
DOI
10.1186/s13046-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-03T13:01:35.605Z
SHA-256 of the archived text
51ad4980d6be175620fec11798fd12f052aaa493cfc4cafd0119e88e2962b70c
Stable URL of this page
https://metraipolis.com/documento/dc_735c5d33cd02

How to cite

Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening — Europe PMC PMID:41923265 — Europe PMC (en), https://europepmc.org/article/MED/41923265 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_735c5d33cd02 (Metraipolis archive dc_735c5d33cd02, sha256 51ad4980d6be175620fec11798fd12f052aaa493cfc4cafd0119e88e2962b70c)
BibTeX
@misc{dc735c5d33cd02,
  title = {Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening — Europe PMC PMID:41923265},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41923265},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_735c5d33cd02; sha256 51ad4980d6be175620fec11798fd12f052aaa493cfc4cafd0119e88e2962b70c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41923265. Agents can read the archived copy with the MCP tool read_document.